These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 3494763

  • 1. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
    Corey AL, Richman DP, Agius MA, Wollmann RL.
    J Immunol; 1987 May 15; 138(10):3269-75. PubMed ID: 3494763
    [Abstract] [Full Text] [Related]

  • 2. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
    Gomez CM, Richman DP.
    J Immunol; 1987 Jul 01; 139(1):73-6. PubMed ID: 3035025
    [Abstract] [Full Text] [Related]

  • 3. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis.
    Krolick KA, Yeh TM, Edlund SA.
    Cell Immunol; 1996 Aug 25; 172(1):10-20. PubMed ID: 8806801
    [Abstract] [Full Text] [Related]

  • 4. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
    Zoda T, Yeh TM, Krolick KA.
    J Immunol; 1991 Jan 15; 146(2):663-70. PubMed ID: 1987281
    [Abstract] [Full Text] [Related]

  • 5. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody.
    Agius MA, Richman DP.
    J Immunol; 1986 Oct 01; 137(7):2195-8. PubMed ID: 3489757
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
    Losen M, Stassen MH, Martínez-Martínez P, Machiels BM, Duimel H, Frederik P, Veldman H, Wokke JH, Spaans F, Vincent A, De Baets MH.
    Brain; 2005 Oct 01; 128(Pt 10):2327-37. PubMed ID: 16150851
    [Abstract] [Full Text] [Related]

  • 7. Use of monoclonal antiacetylcholine receptor antibodies to investigate the macrophage inflammation of acute experimental myasthenia gravis: refractoriness to a second episode of acute disease.
    Corey AL, Richman DP, Shuman CA, Gomez CM, Arnason BG.
    Neurology; 1985 Oct 01; 35(10):1455-60. PubMed ID: 3875805
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
    Gomez CM, Richman DP.
    J Immunol; 1985 Jul 01; 135(1):234-41. PubMed ID: 3873489
    [Abstract] [Full Text] [Related]

  • 9. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E, Klinkert WE, Wekerle H.
    Am J Pathol; 1991 Nov 01; 139(5):995-1008. PubMed ID: 1951638
    [Abstract] [Full Text] [Related]

  • 10. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor.
    Loutrari H, Kokla A, Tzartos SJ.
    Eur J Immunol; 1992 Sep 01; 22(9):2449-52. PubMed ID: 1516631
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Age-related resistance to experimental autoimmune myasthenia gravis in rats.
    Graus YM, Verschuuren JJ, Spaans F, Jennekens F, van Breda Vriesman PJ, De Baets MH.
    J Immunol; 1993 May 01; 150(9):4093-103. PubMed ID: 8386206
    [Abstract] [Full Text] [Related]

  • 13. [Antibodies in myasthenia gravis].
    Eymard B.
    Rev Neurol (Paris); 2009 Feb 01; 165(2):137-43. PubMed ID: 19162288
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.
    Biesecker G, Gomez CM.
    J Immunol; 1989 Apr 15; 142(8):2654-9. PubMed ID: 2703710
    [Abstract] [Full Text] [Related]

  • 15. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S, Galin FS, Kishimoto M, Adachi A, Blalock JB.
    J Immunol; 1996 Jul 01; 157(1):386-92. PubMed ID: 8683141
    [Abstract] [Full Text] [Related]

  • 16. Single-fiber electromyography in experimental autoimmune myasthenia gravis.
    Verschuuren JJ, Spaans F, De Baets MH.
    Muscle Nerve; 1990 Jun 01; 13(6):485-92. PubMed ID: 2366822
    [Abstract] [Full Text] [Related]

  • 17. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes.
    Biesecker G, Koffler D.
    J Immunol; 1988 May 15; 140(10):3406-10. PubMed ID: 3258882
    [Abstract] [Full Text] [Related]

  • 18. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM, Van Den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, Duimel H, Frederik P, Molenaar PC, Martínez-Martínez P, De Baets MH, Losen M.
    Autoimmunity; 2010 Aug 15; 43(5-6):353-70. PubMed ID: 20380584
    [Abstract] [Full Text] [Related]

  • 19. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
    Engel AG, Lambert EH.
    Electroencephalogr Clin Neurophysiol Suppl; 1978 Aug 15; (34):469-77. PubMed ID: 220007
    [Abstract] [Full Text] [Related]

  • 20. Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis.
    Asher O, Kues WA, Witzemann V, Tzartos SJ, Fuchs S, Souroujon MC.
    J Immunol; 1993 Dec 01; 151(11):6442-50. PubMed ID: 8245477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.